Evidence map›Paper›PMID 18080140›Full record

ArticleParasitology research2008

Evaluation of antileishmanial potential of Tinospora sinensis against experimental visceral leishmaniasis.

Nasib Singh, Awanish Kumar, Prasoon Gupta, Kailash Chand, Mukesh Samant, Rakesh Maurya, Anuradha Dube

Abstract read
PubMed Publisher
In one paragraph

Article in Parasitology research, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Therapeutic Potential of Plant Oxylipins.International journal of molecular sciences · 2022
    Review
  2. Metabolic Pathways ofPharmaceutics · 2022
    Review
  3. Review
  4. Identification ofACS omega · 2019
    Article
  5. Genus Tinospora: Ethnopharmacology, Phytochemistry, and Pharmacology.Evidence-based complementary and alternative medicine : eCAM · 2016
    Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Nasib SinghDivision of Parasitology, Central Drug Research Institute, Lucknow 226 001, India.
Awanish Kumar
Prasoon Gupta
Kailash Chand
Mukesh Samant
Rakesh Maurya
Anuradha Dube

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The chemotherapeutic interventions against visceral leishmaniasis (VL) are limited and facing serious concerns of toxicity, high cost, and emerging drug resistance. There is a greater interest in new drug developments from traditionally used medicinal plants which offers unprecedented diversity in structures and bioactivity. With this rationale, ethanolic extract of Tinospora sinensis Linn and its four fractions were tested in vitro against promastigotes and intracellular amastigotes and in vivo in Leishmania donovani infected hamsters. Ethanolic extract exhibited an appreciable activity against promastigotes (IC(50) 37.6+/-6.2 microg/ml) and intracellular amastigotes (IC(50) 29.8+/-3.4 microg/ml). In hamsters, it resulted in 76.2+/-9.2% inhibition at 500 mg/kg/day x 5 oral dose level. Among fractions, n-butanol imparted highest in vitro and in vivo activities. Ethanolic extract and butanol fraction also enhances reactive oxygen species (ROS) and nitric oxide (NO) release. The results indicate that T. sinensis may provide new lead molecules for the development of alternative drugs against VL.

Indexed as

TinosporaAnimalsAntiprotozoal AgentsChloroformCricetinaeDisease Models, AnimalLeishmaniasis, VisceralMacrophagesPlant ExtractsSolventsAntiprotozoal AgentsChloroformPlant ExtractsSolvents

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.